Molecular Diagnostics
Blood Test for Alzheimer's to Be Developed and Commercialized
A developer and supplier of multiplex protein detection arrays and array-based test kits, and a molecular diagnostics company focused on developing blood-based tests will cooperate to develop and commercialize an Alzheimer's disease detection blood test based on plasma biomarkers. More...30 Apr 2009

In Other News
Prostate Cancer Urine Test Based on Gene Fusion
Cold-PCR Enriches DNA Mutations in Samples
Genotyping Panels Detect Polymorphisms and Gene Variants
Multiplex Mass Spectrometric Immunoassays Will Improve Cancer Diagnosis
Blood Test Will Predict Seriousness of Brain Injuries
Transfusable Blood to Be Made From ESCs
Beckman Coulter Augments Genomic Services with Cogenics Acquisition
Amplified DNA Assays Detect Chlamydia Trachomatis and Neisseria Gonorrhoeae
Cardiac Specific C-Reactive Protein Test Extended Across Multiple Platforms
New TB Test Will Dramatically Cut Diagnosis Time
Molecular-Based Test Will Help Pathologists Diagnose Prostate Cancer
Scientists and Nonprofit Organizations Develop Affordable Diagnostics
Set of Genes Identifies Four Known Breast Cancer Types
New Molecular Assays Test for Human Papillomavirus
Direct Relationship Found Between Two Antibodies and AD Severity
LOAC System Could Revolutionize Point-of-Care Diagnostics
MicroRNA Biomarker Successfully Identifies Squamous Lung Cancer
Noninvasive Prenatal Genetic Screening Tests Are Safer
Nanogen Expands Partnership with HandyLab for IVD Testing
Innovative Biosensors Develops Rapid Diagnostics System With Progentech
Two Genes Linked to Common Types of Gliomas
Genome-Wide Expression Analysis Helps Understand Leukemia Development
Heart Attack Risk Determined by Specific Genes
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.